| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
70,287 |
59,258 |
$6.10M |
| 99199 |
Unlisted special service, procedure or report |
635,478 |
384,247 |
$3.72M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
43,398 |
37,769 |
$2.50M |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
42,674 |
38,492 |
$1.59M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
15,875 |
14,294 |
$1.39M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
14,290 |
12,665 |
$1.20M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
13,184 |
11,912 |
$1.16M |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
10,557 |
9,198 |
$630K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
11,641 |
8,835 |
$545K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,766 |
3,484 |
$361K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
24,515 |
22,118 |
$244K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
23,952 |
21,433 |
$213K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
16,106 |
13,417 |
$210K |
| 96127 |
|
26,312 |
23,852 |
$178K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
6,065 |
5,692 |
$162K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
538 |
507 |
$127K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
5,150 |
4,795 |
$104K |
| D0145 |
Oral evaluation for a patient under three years of age |
3,149 |
3,014 |
$102K |
| 99460 |
|
1,387 |
1,325 |
$99K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
1,450 |
1,410 |
$89K |
| 99051 |
|
3,054 |
2,797 |
$74K |
| 99215 |
Prolong outpt/office vis |
627 |
593 |
$74K |
| D1206 |
Topical application of fluoride varnish |
3,152 |
3,014 |
$45K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,123 |
979 |
$39K |
| 87634 |
|
1,043 |
876 |
$29K |
| 99462 |
|
827 |
690 |
$27K |
| 96161 |
|
5,440 |
4,681 |
$19K |
| 0072A |
|
326 |
217 |
$16K |
| 0071A |
|
311 |
223 |
$15K |
| 87631 |
|
176 |
172 |
$14K |
| 0001A |
|
257 |
212 |
$13K |
| 0002A |
|
253 |
197 |
$13K |
| 90461 |
|
20,162 |
18,133 |
$12K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
842 |
415 |
$12K |
| 88738 |
|
1,966 |
1,634 |
$11K |
| 90651 |
|
460 |
442 |
$11K |
| 92558 |
|
22,005 |
19,787 |
$10K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
74 |
70 |
$9K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
906 |
711 |
$8K |
| 90686 |
|
9,325 |
8,586 |
$7K |
| 94760 |
|
48,217 |
40,307 |
$7K |
| 99177 |
|
36,327 |
32,855 |
$6K |
| 99417 |
Prolong home eval add 15m |
35 |
32 |
$6K |
| 94664 |
|
553 |
432 |
$6K |
| 80061 |
Lipid panel |
285 |
259 |
$4K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
223 |
207 |
$4K |
| G9919 |
Screening performed and positive and provision of recommendations |
99 |
95 |
$3K |
| 99383 |
|
25 |
24 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
43 |
40 |
$2K |
| 94010 |
|
70 |
55 |
$2K |
| 90734 |
|
90 |
86 |
$1K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
41 |
39 |
$1K |
| 0081A |
|
19 |
17 |
$1K |
| 90620 |
|
104 |
99 |
$812.73 |
| 85018 |
|
1,517 |
1,495 |
$655.63 |
| 92567 |
|
38 |
29 |
$456.60 |
| 90619 |
|
130 |
120 |
$171.22 |
| 90633 |
|
1,764 |
1,672 |
$170.17 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
620 |
519 |
$132.27 |
| 90656 |
|
818 |
773 |
$102.66 |
| 36416 |
|
25,064 |
22,344 |
$80.02 |
| 90744 |
|
2,162 |
2,012 |
$74.86 |
| 82962 |
|
12 |
12 |
$35.57 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
81 |
68 |
$10.48 |
| 99072 |
|
6,938 |
5,091 |
$0.34 |
| 90680 |
|
4,313 |
4,034 |
$0.00 |
| 90698 |
|
5,213 |
4,827 |
$0.00 |
| 99000 |
|
1,614 |
1,502 |
$0.00 |
| 90647 |
|
129 |
121 |
$0.00 |
| 90716 |
|
156 |
155 |
$0.00 |
| 91307 |
|
688 |
453 |
$0.00 |
| 90696 |
|
64 |
63 |
$0.00 |
| 90677 |
|
65 |
63 |
$0.00 |
| J7609 |
Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg |
87 |
84 |
$0.00 |
| 90670 |
|
9,030 |
8,249 |
$0.00 |
| 91300 |
|
624 |
445 |
$0.00 |
| 90707 |
|
156 |
155 |
$0.00 |
| 90685 |
|
43 |
43 |
$0.00 |
| 90700 |
|
108 |
106 |
$0.00 |
| 90710 |
|
61 |
60 |
$0.00 |
| 91308 |
|
34 |
27 |
$0.00 |
| 90715 |
|
12 |
12 |
$0.00 |